Apžvalga
Akcijų kainos pasikeitimas
24 val.
Dabar
Min
1.21
Max
1.37
Pajamos | 3.7K -5.5M |
|---|---|
Pelnas, tenkantis vienai akcijai | -0.68 |
EBITDA | 13K -4.4M |
Kitas uždarbis | 2026-08-13 |
|---|
Rinkos kapitalizacija | 8.7M 21M |
|---|---|
Ankstesnė atidarymo kaina | -9.21 |
Ankstesnė uždarymo kaina | 1.36 |
Naujienos nuotaikos
By Acuity
39%
61%
125 / 340 reitingas Healthcare
CEL-SCI Corp Grafikas
Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.
Susijusios naujienos
2026-08-03 23:56; UTC
Diversified Healthcare Trust reported second-quarter FFO of $0.16, exceeding estimates. Revenue fell short at $365.39 million, contributing to a decline in after-market trading.
Skaityti
2026-08-03 23:56; UTC
First Solar Inc reported second-quarter revenue of $1.06 billion and a net profit of $423 million. Shares are higher in after-hours trading.
Skaityti
2026-08-03 23:52; UTC
Microsoft shares are lower in after-market hours amid a class action lawsuit alleging misrepresentation of its Copilot products' performance and competitive position.
Skaityti
2026-08-03 23:51; UTC
Marvell Technology plans a conference call for August 27, 2026, and an Investor Day on October 6, 2026. Shares are higher in after-market trading.
Skaityti
2026-08-03 23:51; UTC
Rivian Automotive raises 2026 capital expenditure guidance to $1.7B-$1.8B, shares trade higher in after-market hours amid focus on cost management and production scaling.
Skaityti
2026-08-03 23:51; UTC
JELD-WEN Holding Inc. reported second-quarter revenue of $817.8 million, exceeding forecasts. The company raised its full-year revenue guidance, boosting after-market trading sentiment.
Skaityti
2026-08-03 23:51; UTC
Palantir Technologies reported Q2 revenue of $1.94 billion, exceeding expectations. Shares rose sharply in after-market hours following strong earnings and raised guidance.
Skaityti
2026-08-03 23:51; UTC
Snap Inc. reported a narrower net loss of $163.96 million and revenue of $1.60 billion, exceeding expectations. Shares rose during after-market trading.
Skaityti
2026-08-03 23:46; UTC
Novavax Inc is advancing in after-market trading as it shifts focus to licensing its Matrix-M adjuvant, attracting positive retail investor sentiment ahead of earnings.
Skaityti
2026-08-03 23:46; UTC
CVS Health shares rose in after-market hours following a survey showing increased provider-payer trust scores and improved perceptions of digital tools in healthcare.
Skaityti
2026-08-03 23:46; UTC
Alexandria Real Estate Equities reported a narrower net loss and FFO of $1.73, exceeding estimates. Shares traded higher in after-market hours.
Skaityti
2026-08-03 23:46; UTC
Nova Ltd's after-market shares are higher, bolstered by strong analyst sentiment and a consensus price target of $603.38, reflecting a potential 54.4% return.
Skaityti
2026-08-03 23:46; UTC
Realty Income Corp reported first-quarter revenue of nearly $1.55 billion, with adjusted funds from operations increasing to $1.06 billion. Shares were roughly flat after-market.
Skaityti
2026-08-03 23:41; UTC
Teladoc Health remains effectively unchanged in after-market trading. Citigroup lowered its price target from $11.00 to $7.50 while maintaining a "neutral" rating.
Skaityti
2026-08-03 23:41; UTC
Addus Homecare Corp reported Q2 revenue of $377.4 million and adjusted EPS of $1.73. Shares declined after the earnings announcement amid mixed market reactions.
Skaityti
2026-08-03 23:41; UTC
Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.
Skaityti
2026-08-03 23:41; UTC
DA Davidson raised its price target for First Business Financial Services to $80, contributing to higher shares in after-market trading.
Skaityti
2026-08-03 23:41; UTC
Karyopharm Therapeutics shares are lower in after-market hours following the grant of restricted stock units to a new employee, raising potential dilution concerns.
Skaityti
2026-08-03 23:41; UTC
Andersons Inc. shares rise in after-market trading following strong Q2 results, with adjusted net income of $73.6 million exceeding expectations.
Skaityti
2026-08-03 23:41; UTC
BWX Technologies shares are lower in after-market hours following a revenue miss of $901.6 million and a divestiture of its medical business to Nordic Capital.
Skaityti
2026-08-03 23:41; UTC
Williams Companies announced an agreement to acquire Momentum Midstream for up to $5.5 billion, boosting its natural gas infrastructure and supporting Gulf Coast demand.
Skaityti
2026-08-03 23:41; UTC
Ichor Holdings shares lower in after-market trading following a revenue miss of $294.8 million and EPS of $0.03, below expectations.
Skaityti
2026-08-03 23:31; UTC
Biomarin Pharmaceutical shares are lower in after-market hours amid concerns over stagnant operating margins and below-average returns on capital, raising investor caution.
Skaityti
2026-08-03 23:31; UTC
Ameresco shares rose in after-market trading following strong Q2 results, with revenues of $515.5 million exceeding expectations and a record $1.8 billion in new project awards.
Skaityti
2026-08-03 23:31; UTC
UBS raised its price target on Colgate-Palmolive Co to $109, maintaining a Buy rating. Shares are trading higher in after-market hours.
Skaityti
2026-08-03 23:31; UTC
Grab Holdings reported strong Q2 results, with earnings per share of 6 cents and revenue of $997 million. Shares are higher in after-market hours.
Skaityti
2026-08-03 23:31; UTC
Ultra Clean Holdings reported Q2 net income of $11.9 million and revenue of $644.9 million, raising its Q3 outlook to between $700 million and $750 million.
Skaityti
2026-08-03 23:26; UTC
Vertex Pharmaceuticals reported second-quarter revenue of $3.33 billion, exceeding estimates. The company raised its full-year guidance to between $13.1 billion and $13.2 billion.
Skaityti
2026-08-03 23:21; UTC
Banner Corp announces a buyback of up to 1.7 million shares, aiming to enhance long-term shareholder value. Shares are higher in after-market trading.
Skaityti
2026-08-03 23:21; UTC
Inspire Medical Systems reported Q2 adjusted EPS of $0.14, exceeding expectations. The company raised its full-year EPS guidance to between $1.05 and $1.45.
Skaityti
Akcijų palyginimas
Kainos pokytis
CEL-SCI Corp Prognozė
Bendras įvertinimas
By TipRanks
0 ratings
0
Pirkti
0
Laikyti
0
Parduoti
Remiantis 0 analitikų, pateikusių CEL-SCI Corp akcijų reitingus – Dist per pastaruosius 3 mėnesius.
Rinkos nuotaikos
By Acuity
Naujienos nuotaikos
Bulių rinkos įrodymas
Svyravimai
Žemiau vidurkio
Naujienų apimtis (RCV)
Žemiau vidurkio
Finansinės naujienos
Pardavimo ir administravimo išlaidos
Veiklos sąnaudos
Ikimokestinis pelnas
Pardavimai
Pardavimo savikaina
Bendrasis pelnas iš pardavimo
Skolų palūkanų išlaidos
EBITDA
Veiklos pelnas
$